ERCC4 and cancer: Investigations into DNA repair proteins have identified the Excision Repair Cross Complementation Group 1 (ERCC1) and Xeroderma Pigmentosum Complementation Group F (XPF) complex as being more highly expressed in cancer cell lines that exhibit chemoresistance (Weeda et al., 1997).